Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies
Saathvik R Kannan, Austin N Spratt, Kalicharan Sharma, Hitendra S Chand, Siddappa N Byrareddy, Kamal Singh, Saathvik R Kannan, Austin N Spratt, Kalicharan Sharma, Hitendra S Chand, Siddappa N Byrareddy, Kamal Singh
Abstract
Severe Acute Respiratory Coronavirus (SARS-CoV-2) has been emerging in the form of different variants since its first emergence in early December 2019. A new Variant of Concern (VOC) named the Omicron variant (B.1.1.529) was reported recently. This variant has a large number of mutations in the S protein. To date, there exists a limited information on the Omicron variant. Here we present the analyses of mutation distribution, the evolutionary relationship of Omicron with previous variants, and probable structural impact of mutations on antibody binding. Our analyses show the presence of 46 high prevalence mutations specific to Omicron. Twenty-three of these are localized within the spike (S) protein and the rest localized to the other 3 structural proteins of the virus, the envelope (E), membrane (M), and nucleocapsid (N). Phylogenetic analysis showed that the Omicron is closely related to the Gamma (P.1) variant. The structural analyses showed that several mutations are localized to the region of the S protein that is the major target of antibodies, suggesting that the mutations in the Omicron variant may affect the binding affinities of antibodies to the S protein.
Keywords: B.1.1.529; COVID-19; Omicron variant; SARS-CoV-2; Variants.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Figures
References
- Rothan H.A., Byrareddy S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 2020;109
- Kim D., Lee J.Y., Yang J.S., Kim J.W., Kim V.N., Chang H. The architecture of SARS-CoV-2 transcriptome. Cell. 2020;181:914–921 e10.
- Mariano G., Farthing R.J., Lale-Farjat S.L.M., Bergeron J.R.C. Structural characterization of SARS-CoV-2: where we are, and where we need to Be. Front Mol Biosci. 2020;7
- Kannan S.R., Spratt A.N., Cohen A.R., Naqvi S.H., Chand H.S., Quinn T.P., et al. Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses. J. Autoimmun. 2021;124
- Callaway E. Heavily mutated Omicron variant puts scientists on alert. Nature. 2021;600:21.
- Torjesen I. Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear. BMJ. 2021;375:n2943.
- Gao S.J., Guo H., Luo G. Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert. J. Med. Virol. 2021
- Elbe S., Buckland-Merrett G. Data, disease and diplomacy: GISAID's innovative contribution to global health. Glob Chall. 2017;1:33–46.
- Hadfield J., Megill C., Bell S.M., Huddleston J., Potter B., Callender C., et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018;34:4121–4123.
- Kannan S.R., Spratt A.N., Quinn T.P., Heng X., Lorson C.L., Sonnerborg A., et al. Infectivity of SARS-CoV-2: there is something more than D614G? J. Neuroimmune Pharmacol. 2020;15:574–577.
- Korber B., Fischer W.M., Gnanakaran S., Yoon H., Theiler J., Abfalterer W., et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182:812–827 e19.
- Katoh K., Standley D.M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 2013;30:772–780.
- Spratt A.N., Kannan S.R., Woods L.T., Weisman G.A., Quinn T.P., Lorson C.L., et al. Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants. Comput. Struct. Biotechnol. J. 2021;19:3799–3809.
- Venkatakrishnan A., Anand P., Lenehan P., Suratekar R., Raghunathan B., Niesen M.J., Soundararajan V. APA; MLA; Chicago: 2021. Omicron Variant of SARS-CoV-2 Harbors a Unique Insertion Mutation of Putative Viral or Human Genomic Origin. December 3.
- Wu N.C., Yuan M., Liu H., Lee C.D., Zhu X., Bangaru S., et al. bioRxiv; 2020. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain.
- Vogel A.B., Kanevsky I., Che Y., Swanson K.A., Muik A., Vormehr M., et al. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature. 2021;592:283–289.
Source: PubMed